Rifapentine plus isoniazid for latent tuberculosis infection in Brazil: a retrospective cohort study

被引：0
|
作者：
Chaves, Beatriz [1 ]
Souza, Ana Carolina [1 ]
Leung, Janaina [1 ]
Costa, Walter [1 ]
Santos, Ana Paula [1 ]
机构：
[1] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA1468
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees
    Ilaiwy, Ghassan
    Dowdy, David W.
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2021, 24
  • [32] Update of the Recommendations for the Use of Once-Weekly Isoniazid-Rifapentine Regimen to Latent Mycobaterium tuberculosis Infection
    Alabaz, Derya
    JOURNAL OF PEDIATRIC INFECTION, 2019, 13 (01): : E58 - E61
  • [33] COMBINED USE OF ISONIAZID AND RIFAPENTINE IN THE TREATMENT OF LATENT TUBERCULOSIS: A BUDGET IMPACT ANALYSIS
    Sena, R. R.
    Wichmann, R. M.
    Silva, M. T.
    VALUE IN HEALTH, 2017, 20 (09) : A928 - A928
  • [34] Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts
    Schechter, M
    Zajdenverg, R
    Falco, G
    Barnes, GL
    Faulhaber, JC
    Coberly, JS
    Moore, RD
    Chaisson, RE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (08) : 922 - 926
  • [35] Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis
    Chen, Yi-Ming
    Liao, Tsai-Ling
    Chen, Hsin-Hua
    Chen, Der-Yuan
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (11) : 1688 - +
  • [36] Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study
    Lam, Chee Kin
    Pilote, Kara McGinnis
    Haque, Ashraful
    Burzynski, Joseph
    Chuck, Christine
    Macaraig, Michelle
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2018, 20 (11)
  • [37] Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan
    Huang, Shiang-Fen
    Chen, Ming-Han
    Wang, Fu-Der
    Tsai, Chang-Youh
    Fung, Chang-Phone
    Su, Wei-Juin
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2018, 51 (06) : 784 - 793
  • [38] Genetic and clinical predictors of rifapentine and isoniazid pharmacokinetics in paediatrics with tuberculosis infection
    Phaisal, Weeraya
    Albitar, Orwa
    Chariyavilaskul, Pajaree
    Jantarabenjakul, Watsamon
    Wacharachaisurapol, Noppadol
    Ghadzi, Siti Maisharah Sheikh
    Zainal, Hadzliana
    Harun, Sabariah Noor
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (06) : 1270 - 1278
  • [39] COMPARISON OF DIRECTLY OBSERVED ISONIAZID-RIFAPENTINE WITH SELF ADMINISTERED ISONIAZID AND RIFAMPIN REGIMENS FOR LATENT TUBERCULOSIS INFECTION-A PUBLIC HEALTH PERSPECTIVE
    Yamin, A.
    Kempker, R.
    Bornstein, E.
    Hensen, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (02) : 472 - 472
  • [40] One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
    Stout, Jason E.
    Sterling, Timothy R.
    Horsburgh, C. Robert, Jr.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (11):
12345